Skin Diseases  >>  betamethasone/calcipotriol (BFH 772)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
betamethasone/calcipotriol (BFH 772) / Novartis
NCT00987870 / 2008-002795-96: Safety and Efficacy of BFH772 in Psoriasis Patients

Completed
1/2
15
Europe
BFH772, Placebo, calcipotriol/betamethasone
Novartis Pharmaceuticals
Psoriasis, Arthritis
02/10
 

Download Options